2 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Scleroderma, Limited: new trials by email Literature Review of Scleroderma, Limited trials Research Report on Scleroderma, Limited
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine treprostinil diethanolamine, placebo - Systemic Sclerosis, Scleroderma | Phase 2 | Completed | United Therapeutics | 148 | 2009-05-01 | 2023-12-28 |
| Effectiveness and Safety of Lidocaine for Scleroderma Lidocaine 2% without vessel constrictor, Placebo - physiological solution 0,9% - Scleroderma | Phase 2 / Phase 3 | Completed | Federal University of São Paulo | 26 | 2004-04-01 | 2008-08-22 |
Scleroderma, Diffuse (2) · Scleroderma, Systemic (1) · Ulcer (1)
Connective Tissue Diseases (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Scleroderma, Systemic (1)
Lidocaine (1) · treprostinil (1)
Federal University of São Paulo (1) · United Therapeutics (1)
Brazil (1) · Canada (1) · United Kingdom (1) · United States (1)
Alexandre WS Silva, PhD (1) · James Seibold, MD (1) · Rachel Riera, MD (1) · Virginia FM Trevisani, PhD (1)